ASSENT 4

ASSENT 4

Assessment of the Safety & Efficacy of a New Treatment Strategy for Acute Myocardial Infarction. An ongoing trial assessing a bolus thrombolytic (Metalyse®/TNKase™ tenecteplase + PCI, aka primary angioplasty) for treating acute myocardial infarction.